FDA Approves New Treatment for Soft Tissue Sarcoma
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Author:
Karen Honey, PhD
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Earlier this week, the U.S. Food and Drug Association (FDA) announced it had approved the immunotherapeutic atezolizumab (Tecentriq) for...
Understanding the identity of the factors that increase risk for a particular type of cancer is vital for developing...
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
One of the most effective ways a person can lower his or her risk of developing cancer is by...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...
With warm weather finally here, bringing more people outdoors, it is important to remember that many cases of skin...